Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clozapine in bipolar disorder: A systematic review and meta-analysis
A. Delgado, J. Velosa, Junyu Zhang, et al.
Journal of Psychiatric Research (2020) Vol. 125, pp. 21-27
Closed Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Clozapine for bipolar disorder: What do we know so far and what next?
Flávio Kapczinski, Bianca Pfaffenseller, Serdar Dursun, et al.
Bipolar Disorders (2021) Vol. 23, Iss. 2, pp. 115-116
Closed Access | Times Cited: 10
Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors
Jorge A. Sánchez-Ruiz, Brandon J. Coombes, Richard Pendegraft, et al.
Psychiatry Research (2023) Vol. 323, pp. 115174-115174
Closed Access | Times Cited: 3
Analysis of Appendicitis Cases in the Japanese Adverse Drug Event Report (JADER) Database
Yoji Kyotani, Jing Zhao, Kiichi Nakahira, et al.
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 5, pp. 655-660
Open Access | Times Cited: 3
Mapping the scientific research on bipolar disorder: A scientometric study of hotspots, bursts, and trends
Wenjun Zhu, Naijun Yuan, Chunmiao Wan, et al.
Journal of Affective Disorders (2023) Vol. 340, pp. 626-638
Open Access | Times Cited: 3
Measurement of the Antipsychotic Clozapine Using Reduced Graphene Oxide Nanocomposites‐Au/Pd/Pt Electrodes
Mehmet Şenel, Z. Durmuş, Amal Alachkar
Electroanalysis (2021) Vol. 33, Iss. 6, pp. 1585-1595
Closed Access | Times Cited: 6
<p>Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital</p>
Wenying Yi, Shenglin She, Jie Zhang, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 2827-2836
Open Access | Times Cited: 5
Clozapine: A special case of an atypical antipsychotic
Elina Marinho
European Journal of Medicinal Chemistry Reports (2024) Vol. 10, pp. 100140-100140
Open Access
A case series of COVID-19-related catatonia: A focus on immunological and neural mechanisms
Claudia Del Grande, Simone Gasparini, Barbara Capovani, et al.
Psychiatry Research Case Reports (2024) Vol. 3, Iss. 1, pp. 100222-100222
Open Access
Bipolar Disorder
Jennifer Burgess, Alan Currie, Stuart Watson, et al.
Cambridge University Press eBooks (2024), pp. 162-182
Closed Access
A reevaluation of mixed depressive states from the DSM-5- TR perspective: a series of prototypical cases
Stefano Pini, Accursio Raia, Giulia Amatori
Archive of Clinical Cases (2024) Vol. 11, Iss. 1, pp. 22-28
Open Access
Electroconvulsive Therapy Combined with the Treatments of Clozapine and Aripiprazole in a Patient with Treatment-resistant Mania: A Case Report
Ya-Ching Tsai, Ching-Hua Lin
Taiwanese Journal of Psychiatry (2024) Vol. 38, Iss. 2, pp. 99-101
Open Access
Clozapine as a mood stabiliser for schizoaffective disorder: Effectiveness during a three-month follow-up
Marc Peraire, Francisco Arnau-Peiró, Ana Benito, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111090-111090
Open Access
Treatment-Resistant Bipolar Disorder
Stavroula Rakitzi, Polyxeni Georgila
(2024), pp. 15-47
Closed Access
Bipolar disorder
Scott C. Fears, Walter S. Dunn, Victor I. Reus
Elsevier eBooks (2024), pp. 903-925
Closed Access
<p>Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China</p>
Liu Yang, Jun Liang, Qingrong Xia, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 2623-2632
Open Access | Times Cited: 3
Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder
R Tabrisi, MD Harun-Rashid, José Garnacho‐Montero, et al.
Psychopharmacology (2023) Vol. 240, Iss. 8, pp. 1667-1676
Open Access | Times Cited: 1
Safety aspects during treatment with clozapine:
Stefan J. Berger, Alex Hofer
Neuropsychiatrie (2023) Vol. 37, Iss. 3, pp. 122-129
Open Access | Times Cited: 1
Clozapine for management of bipolar disorder: A case series
Sandeep Grover, Promil Redhu
Journal of SAARC Psychiatric Federation (2023) Vol. 1, Iss. 1, pp. 56-59
Closed Access
Con qué medicamentos están siendo tratados los pacientes con trastorno afectivo bipolar en Colombia
Jorge Enrique Machado-Alba, Alejandra Fonseca, Manuel Enrique Machado‐Duque, et al.
Universidad y Salud (2023) Vol. 25, Iss. 2, pp. 27-32
Open Access
Manzoni and agoraphobia – Psychiatry in literature
Luca Cambioli, M Riva
The British Journal of Psychiatry (2023) Vol. 223, Iss. 4, pp. 464-464
Open Access
Efficacy and safety of Jie-du-qing-nao granules for first-episode schizophrenics: study protocol for a randomized controlled trial
Ziyan Li, Yanzhe Ning, Pei Chen, et al.
Research Square (Research Square) (2020)
Open Access
Découverte d’une cardiomyopathie dilatée chez un patient schizophrène traité par clozapine
Flora Marchandise, C. Lo Presti, Matthieu Peretti, et al.
Le Pharmacien Clinicien (2022) Vol. 58, Iss. 1, pp. 59-64
Closed Access
Perspective Chapter: NMDA Treatments for CNS Disorders
Chih-Hung Lin, Po‐Chang Shih, Guochuan Tsai
IntechOpen eBooks (2021)
Open Access
Bipolar Disorder

(2021), pp. 247-304
Closed Access
“Golden Shot” in the Treatment and Diagnosis of Schizophrenia: Psychiatrists or Neuroscientists?
Irina Vladimirovna Dubatova, Lema Andreevich Antsyborov, Artur Fedorovich Kheigetian, et al.
Interactive science (2021), Iss. 10 (65), pp. 9-24
Open Access
Previous Page - Page 2

Scroll to top